HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro.

Abstract
Ramatroban (Baynas, BAY u3405), a thromboxane A(2) (TxA(2)) antagonist marketed for allergic rhinitis, has been shown to partially attenuate prostaglandin (PG)D(2)-induced bronchial hyperresponsiveness in humans, as well as reduce antigen-induced early- and late-phase inflammatory responses in mice, guinea pigs, and rats. PGD(2) is known to induce eosinophilia following intranasal administration, and to induce eosinophil activation in vitro. In addition to the TxA(2) receptor, PGD(2) is known as a ligand for the PGD(2) receptor, and the newly identified G-protein-coupled chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). To fully characterize PGD(2)-mediated inflammatory responses relevant to eosinophil activation, further analysis of the mechanism of action of ramatroban has now been performed. PGD(2)-stimulated human eosinophil migration was shown to be mediated exclusively through activation of CRTH2, and surprisingly, these effects were completely inhibited by ramatroban. This is also the first report detailing an orally bioavailable small molecule CRTH2 antagonist. Our findings suggest that clinical efficacy of ramatroban may be in part mediated through its action on this Th2-, eosinophil-, and basophil-specific chemoattractant receptor.
AuthorsHiromi Sugimoto, Michitaka Shichijo, Takashi Iino, Yoshihisa Manabe, Akihiko Watanabe, Makoto Shimazaki, Florian Gantner, Kevin B Bacon
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 305 Issue 1 Pg. 347-52 (Apr 2003) ISSN: 0022-3565 [Print] United States
PMID12649388 (Publication Type: Journal Article)
Chemical References
  • Carbazoles
  • Platelet Aggregation Inhibitors
  • Receptors, Immunologic
  • Receptors, Prostaglandin
  • Sulfonamides
  • ramatroban
  • Prostaglandin D2
  • Calcium
  • prostaglandin D2 receptor
Topics
  • Administration, Oral
  • Biological Availability
  • Calcium (metabolism)
  • Carbazoles (pharmacology)
  • Cell Movement
  • Drug Interactions
  • Eosinophils (drug effects, physiology)
  • Humans
  • In Vitro Techniques
  • Platelet Aggregation Inhibitors (pharmacology)
  • Prostaglandin D2 (antagonists & inhibitors, pharmacology)
  • Receptors, Immunologic (antagonists & inhibitors)
  • Receptors, Prostaglandin
  • Sulfonamides (pharmacology)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: